Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Genetic 'sensor' spots and kill cells with key cancer gene

20 November 2017

By Marcia Costa

Appeared in BioNews 927

A team of scientists in Germany has developed a 'sensor' that detects mutations in the key tumour suppressor gene p53 and then kills potentially cancerous cells. The research was published this month in Nature Communications.

The p53 gene is part of a family of genes that prevents cells from proliferating in an uncontrolled manner, which results in cancer. Mutations that stop p53 from working are implicated in 50 percent of human cancers, and many biotechnology companies have developed drugs to target the gene.

In this study, the multicentre team from Dresden created a molecular sensor that detects when early changes occur in the p53 gene. This sensor takes the form of a genetic element that makes a cell reliant on normal p53 – any mutations which disable the gene activate the sensor and trigger cell death mechanisms, so preventing tumour formation.

This would be a novel way to deal with cancer, according to project leader Professor Frank Buchholz at University Hospital Carl Gustav Carus. 'We treat cancer cells long after they have gone through the transformation process,' he noted. With the team's new approach, prevention would be the key.

'The p53 sensor enables an active precocious intervention for the first time,' said Professor Buchholz. 'Our results show that cells with p53 mutations can be selectively detected and eliminated at an early stage. Hence, the transformation process is prevented.'

The team has, so far, tested this sensor in vitro and in vivo in a mouse model. These new findings, though, open doors to develop new techniques for cancer diagnosis. It might even be possible to adapt this sensor for other genes.

SOURCES & REFERENCES
Nature Communications | 13 November 2017
 
Labiotech.eu | 16 November 2017
 
Science Daily | 14 November 2017
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

18 December 2017 - by Dr Loredana Guglielmi 
Scientists in the USA have found a novel non-coding gene that alters proliferation in cancer cells to help tumour development...

19 October 2017 - by Charlott Repschlager 
Between one and 10 mutations are required for a healthy cell to turn cancerous...
21 August 2017 - by Marcia Costa 
Genes linked to 17 types of cancer have been mapped in a new Pathology Atlas by Swedish researchers...
08 August 2016 - by Amina Yonis 
More than half of patients with sarcoma, a rare cancer, have mutations that are known to increase the risk of other types of cancer...
21 October 2013 - by Dr Naqash Raja 
Common gene mutations link 12 cancer types such as blood, colon and kidney, research from Washington University School of Medicine, USA, has shown...
07 May 2013 - by Suzanne Elvidge 
Genetic analysis of tumours provides the key to treating them effectively, according to two studies carried out by The Cancer Genome Atlas (TCGA)....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation